| http://www.w3.org/ns/prov#value | - In determining the effective amount of the vector to be administered in the treatment or prophylaxis of virally-mediated diseases such as AIDS, the physician evaluates circulating plasma levels, vector and ribozyine toxicities, progression of the
|
